Details for New Drug Application (NDA): 200170
✉ Email this page to a colleague
The generic ingredient in DOXORUBICIN HYDROCHLORIDE is doxorubicin hydrochloride. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the doxorubicin hydrochloride profile page.
Summary for 200170
Tradename: | DOXORUBICIN HYDROCHLORIDE |
Applicant: | Mylan Labs Ltd |
Ingredient: | doxorubicin hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 200170
Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 200170
Suppliers and Packaging for NDA: 200170
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 200170 | ANDA | Mylan Institutional LLC | 67457-436 | 67457-436-50 | 1 VIAL in 1 CARTON (67457-436-50) / 25 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
Approval Date: | Oct 28, 2011 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/VIAL | ||||
Approval Date: | Oct 28, 2011 | TE: | AP | RLD: | No |
Complete Access Available with Subscription